Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
268
-
Total 13F shares, excl. options
-
52.9M
-
Shares change
-
+74.8K
-
Total reported value, excl. options
-
$1.75B
-
Value change
-
-$145K
-
Put/Call ratio
-
0.77
-
Number of buys
-
120
-
Number of sells
-
-144
-
Price
-
$33.09
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2019
324 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2019.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.9M shares
of 56M outstanding shares and own 94.35% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.19M shares), VANGUARD GROUP INC (5.35M shares), STATE STREET CORP (1.73M shares), Champlain Investment Partners, LLC (1.59M shares), DIMENSIONAL FUND ADVISORS LP (1.44M shares), RICE HALL JAMES & ASSOCIATES, LLC (1.35M shares), MACQUARIE GROUP LTD (1.08M shares), GLENMEDE TRUST CO NA (1.05M shares), Bank of New York Mellon Corp (1.03M shares), and LOOMIS SAYLES & CO L P (1M shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.